Kenji Arimitsu
- Organic Chemistry
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging
- Pulmonary and Respiratory Medicine
- Oncology
- Co-authors
- Hideo SajiMasahiro OnoHiroyuki KimuraKana YamamotoTetsuya KajimotoYusuke YagiHiroki IwasakiMasayuki Yamashita
- Topics
- Radiopharmaceutical Chemistry and Applications (8 papers)Peptidase Inhibition and Analysis (5 papers)Asymmetric Hydrogenation and Catalysis (5 papers)
- Cited by
- Organic ChemistryRadiology, Nuclear Medicine and ImagingEndocrinology, Diabetes and Metabolism
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Kenji Arimitsu
50 papers receiving 385 citations
Peers
Comparison fields: 5 of 82
- Organic Chemistry 133
- Molecular Biology 101
- Radiology, Nuclear Medicine and Imaging 72
- Pulmonary and Respiratory Medicine 61
- Oncology 59
Countries citing papers authored by Kenji Arimitsu
This map shows the geographic impact of Kenji Arimitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Arimitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Arimitsu more than expected).
Fields of papers citing papers by Kenji Arimitsu
This network shows the impact of papers produced by Kenji Arimitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Arimitsu. The network helps show where Kenji Arimitsu may publish in the future.
Co-authorship network of co-authors of Kenji Arimitsu
This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Arimitsu. A scholar is included among the top collaborators of Kenji Arimitsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Arimitsu. Kenji Arimitsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | 7 | |
| 8 | 14 | |
| 9 | 16 | |
| 10 | 12 | |
| 11 | 3 | |
| 12 | 35 | |
| 13 | 16 | |
| 14 | 10 | |
| 15 | 12 | |
| 16 | 11 | |
| 17 | 13 | |
| 18 | 1 | |
| 19 | 8 | |
| 20 | 6 |
About Kenji Arimitsu
Kenji Arimitsu is a scholar working on Organic Chemistry, Toxicology and Radiology, Nuclear Medicine and Imaging, having authored 52 papers that have together received 394 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (8 papers), Peptidase Inhibition and Analysis (5 papers) and Asymmetric Hydrogenation and Catalysis (5 papers). The work is most often cited by research in Organic Chemistry (133 citations), Radiology, Nuclear Medicine and Imaging (72 citations) and Endocrinology, Diabetes and Metabolism (40 citations). Kenji Arimitsu has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Hideo Saji, Masahiro Ono, Hiroyuki Kimura, Hiroyuki Kimura, Kana Yamamoto, Tetsuya Kajimoto, Yusuke Yagi, Hiroki Iwasaki, Masayuki Yamashita and Minoru Ozeki. Their work appears in journals such as PLoS ONE, Chemical Communications and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.